Biosimilars Investment Trends 2019

We asked commercialisation experts from the biosimilars industry about how they are investing in their development, and market access strategy.

Download this piece to learn about:

• The reasons why companies aren't currently outsourcing 
• The biggest factors in choosing a new solution provider
• The biggest challenges in biosimilar commercialisation currently